<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title><![CDATA[Medical - Newslocker]]></title><link>https://www.newslocker.com/en-us/news/medical/</link><atom:link rel="self" href="https://www.newslocker.com/en-us/news/medical/rss/" /><atom:link rel="hub" href="http://pubsubhubbub.appspot.com" /><description><![CDATA[Find your latest Medical news with just one click. Don't miss out on anything happening!]]></description><language>en-us</language><copyright>Copyright (C) 2026 newslocker.com</copyright><lastBuildDate>Wed, 03 Jun 2026 23:24:00 +0200</lastBuildDate><item><title><![CDATA[FDA OKs Inflatable Penile Prosthesis for Erectile Dysfunction]]></title><description><![CDATA[(MedPage Today) -- The FDA approved the Titan Prime inflatable penile prosthesis for men with erectile dysfunction, Coloplast announced on Wednesday.<br />
This prosthesis is indicated for men who are considered to be candidates for implantation of...]]></description><link>https://www.newslocker.com/en-us/news/medical/fda-oks-inflatable-penile-prosthesis-for-erectile-dysfunction/</link><pubDate>Wed, 03 Jun 2026 23:24:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/news/medical/fda-oks-inflatable-penile-prosthesis-for-erectile-dysfunction/</guid></item><item><title><![CDATA[CAR T-Cell Therapy Enabled Kidney Transplant in Highly Sensitized Patients]]></title><description><![CDATA[(MedPage Today) -- Patients highly sensitized to HLA successfully underwent kidney transplantation after desensitization with the use of dual chimeric antigen receptor (CAR) T-cell therapy.<br />
In a safety run-in cohort of an ongoing phase I trial...]]></description><link>https://www.newslocker.com/en-us/news/medical/car-t-cell-therapy-enabled-kidney-transplant-in-highly-sensitized-patients/</link><pubDate>Wed, 03 Jun 2026 23:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/news/medical/car-t-cell-therapy-enabled-kidney-transplant-in-highly-sensitized-patients/</guid></item><item><title><![CDATA[PCOS Was Rebranded As PMOS. We Have Reservations.]]></title><description><![CDATA[(MedPage Today) -- The name of a condition that affects between 6-10% of all reproductive-age women was recently changed from PCOS (polycystic ovary syndrome) to PMOS (polyendocrine metabolic ovarian syndrome) by an international consensus process...]]></description><link>https://www.newslocker.com/en-us/news/medical/pcos-was-rebranded-as-pmos-we-have-reservations/</link><pubDate>Wed, 03 Jun 2026 22:47:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/news/medical/pcos-was-rebranded-as-pmos-we-have-reservations/</guid></item><item><title><![CDATA[Hantavirus Cruise Passengers Being Surveilled at Home Around the Clock]]></title><description><![CDATA[(MedPage Today) -- Of the five people exposed to hantavirus on a cruise ship who left a Nebraska quarantine facility for their home states, two passengers went to New York, and one each went to Arizona, California, and Oregon.<br />
At least some of...]]></description><link>https://www.newslocker.com/en-us/news/medical/hantavirus-cruise-passengers-being-surveilled-at-home-around-the-clock/</link><pubDate>Wed, 03 Jun 2026 22:40:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/news/medical/hantavirus-cruise-passengers-being-surveilled-at-home-around-the-clock/</guid></item><item><title><![CDATA[CAR T-Cell Trial in Rheumatoid Arthritis Starts Off Strong]]></title><description><![CDATA[(MedPage Today) -- LONDON--Most patients with super-refractory, seropositive rheumatoid arthritis (RA) responded well to chimeric antigen receptor (CAR) T-cell therapy in the first part of an ongoing phase I/II trial, a researcher reported...]]></description><link>https://www.newslocker.com/en-us/news/medical/car-t-cell-trial-in-rheumatoid-arthritis-starts-off-strong/</link><pubDate>Wed, 03 Jun 2026 22:31:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/news/medical/car-t-cell-trial-in-rheumatoid-arthritis-starts-off-strong/</guid></item><item><title><![CDATA[Investigational ADC Ups Survival in Advanced Triple-Negative Breast Cancer]]></title><description><![CDATA[(MedPage Today) -- CHICAGO--Treatment with investigational izalontamab brengitecan (iza-bren) significantly improved progression-free survival (PFS) and overall survival (OS) in patients with unresectable locally advanced or metastatic triple...]]></description><link>https://www.newslocker.com/en-us/news/medical/investigational-adc-ups-survival-in-advanced-triple-negative-breast-cancer/</link><pubDate>Wed, 03 Jun 2026 22:25:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/news/medical/investigational-adc-ups-survival-in-advanced-triple-negative-breast-cancer/</guid></item><item><title><![CDATA[Senators Clash Over Youth Gender Care Bans]]></title><description><![CDATA[(MedPage Today) -- As the Trump administration continues to target gender-affirming care for youth, the Senate Health, Education, Labor and Pensions (HELP) committee debated the issue in a hearing on Wednesday.<br />
Committee members heard testimony...]]></description><link>https://www.newslocker.com/en-us/news/medical/senators-clash-over-youth-gender-care-bans/</link><pubDate>Wed, 03 Jun 2026 21:14:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/news/medical/senators-clash-over-youth-gender-care-bans/</guid></item><item><title><![CDATA[More Youths Report Using AI Chatbots for Mental Health Advice]]></title><description><![CDATA[(MedPage Today) -- Roughly one in five young people used an artificial intelligence (AI) chatbot for mental health advice last year, a cross-sectional, nationally representative survey showed.<br />
Among youths ages 12 to 21, 19.2% said that they had...]]></description><link>https://www.newslocker.com/en-us/news/medical/more-youths-report-using-ai-chatbots-for-mental-health-advice/</link><pubDate>Wed, 03 Jun 2026 20:51:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/news/medical/more-youths-report-using-ai-chatbots-for-mental-health-advice/</guid></item><item><title><![CDATA[Deaths of Despair Drop; FDA Rejects ADHD Drug; Rafael Nadal's Anxiety Battle]]></title><description><![CDATA[(MedPage Today) -- Deaths of despair--fatalities from drugs, alcohol, and suicide--declined by 16% in 2024, according to a report from Trust for America's Health.<br />
Georgia's Pathways to Coverage--a Medicaid expansion program that conditions...]]></description><link>https://www.newslocker.com/en-us/news/medical/deaths-of-despair-drop-fda-rejects-adhd-drug-rafael-nadals-anxiety-battle/</link><pubDate>Wed, 03 Jun 2026 20:11:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/news/medical/deaths-of-despair-drop-fda-rejects-adhd-drug-rafael-nadals-anxiety-battle/</guid></item><item><title><![CDATA[The U.S. Ebola Response Is a Harbinger of Worse Things to Come]]></title><description><![CDATA[(MedPage Today) -- Last summer, the Kiel Institute, a non-profit think tank in Germany, asked me to lead an analysis of the global benefits of international health aid programs, such as the Global Fund, the President's Emergency Plan for AIDS Relief...]]></description><link>https://www.newslocker.com/en-us/news/medical/the-us-ebola-response-is-a-harbinger-of-worse-things-to-come/</link><pubDate>Wed, 03 Jun 2026 19:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/news/medical/the-us-ebola-response-is-a-harbinger-of-worse-things-to-come/</guid></item><item><title><![CDATA[Supporting Patient Autonomy in Vaccine Conversations]]></title><description><![CDATA[(MedPage Today) -- In "Beyond Diagnosis: Vaccines," Cleveland Clinic infectious disease specialist Donald Dumford III, MD, and host John Mangels continue their conversations on communicating effectively and empathetically with patients around vaccination...]]></description><link>https://www.newslocker.com/en-us/news/medical/supporting-patient-autonomy-in-vaccine-conversations/</link><pubDate>Wed, 03 Jun 2026 18:47:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/news/medical/supporting-patient-autonomy-in-vaccine-conversations/</guid></item><item><title><![CDATA[For Egg Allergy Oral Immunotherapy, Low-Dose Liquid May Be a Key to Success]]></title><description><![CDATA[(MedPage Today) -- For egg-allergic children, an oral immunotherapy (OIT) protocol using low-dose liquid egg to start appeared to be the most successful in inducing tolerance in the outpatient setting, according to one academic center's experience...]]></description><link>https://www.newslocker.com/en-us/news/medical/for-egg-allergy-oral-immunotherapy-low-dose-liquid-may-be-a-key-to-success/</link><pubDate>Wed, 03 Jun 2026 18:24:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/news/medical/for-egg-allergy-oral-immunotherapy-low-dose-liquid-may-be-a-key-to-success/</guid></item><item><title><![CDATA[Combating Cancer-Related Fatigue: Yoga, Bupropion, Exercise Plus Methylphenidate]]></title><description><![CDATA[(MedPage Today) -- CHICAGO--A month-long structured yoga program helped patients with cancer improve mood disturbance, anxiety, and fatigue, contributing to a reduction in insomnia, a large multicenter randomized trial showed.<br />
Scores on tests...]]></description><link>https://www.newslocker.com/en-us/news/medical/combating-cancer-related-fatigue-yoga-bupropion-exercise-plus-methylphenidate/</link><pubDate>Wed, 03 Jun 2026 18:08:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/news/medical/combating-cancer-related-fatigue-yoga-bupropion-exercise-plus-methylphenidate/</guid></item><item><title><![CDATA['Out of My Lane': Dr. Oz Ducks Questions During Turn in White House Briefing Room]]></title><description><![CDATA[(MedPage Today) -- He spoke fast, hammering through the Trump administration's efforts to lower prescription drug prices, combat healthcare fraud, and curb the spread of Ebola overseas.<br />
But when reporters tried to ask Mehmet Oz, MD, MBA, about...]]></description><link>https://www.newslocker.com/en-us/news/medical/out-of-my-lane-dr-oz-ducks-questions-during-turn-in-white-house-briefing-room/</link><pubDate>Wed, 03 Jun 2026 17:34:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/news/medical/out-of-my-lane-dr-oz-ducks-questions-during-turn-in-white-house-briefing-room/</guid></item><item><title><![CDATA[Scientists Charged With Bringing Deactivated Mpox Into U.S., Lying to Authorities]]></title><description><![CDATA[(MedPage Today) -- Two scientists at a U.S. government lab were charged with smuggling vials of deactivated mpox virus into the country from Africa and lying about it during interviews with investigators at a Michigan airport, authorities said...]]></description><link>https://www.newslocker.com/en-us/news/medical/scientists-charged-with-bringing-deactivated-mpox-into-us-lying-to-authorities/</link><pubDate>Wed, 03 Jun 2026 17:32:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/news/medical/scientists-charged-with-bringing-deactivated-mpox-into-us-lying-to-authorities/</guid></item><item><title><![CDATA[HHS Screens NIH Grants; NIAID Gag Order; Children's Health Defense Windfall]]></title><description><![CDATA[(MedPage Today) -- All grants approved by the NIH for funding are now going through extra screening at HHS. HHS staffers--who may be political appointees and not subject matter experts--have sometimes asked to make substantive changes to...]]></description><link>https://www.newslocker.com/en-us/news/medical/hhs-screens-nih-grants-niaid-gag-order-childrens-health-defense-windfall/</link><pubDate>Wed, 03 Jun 2026 17:21:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/news/medical/hhs-screens-nih-grants-niaid-gag-order-childrens-health-defense-windfall/</guid></item><item><title><![CDATA['Provocative' Survival Result in Myelofibrosis Trial]]></title><description><![CDATA[(MedPage Today) -- CHICAGO--A randomized trial testing the addition of selinexor (Xpovio) to ruxolitinib (Jakafi) for myelofibrosis only met one of its two primary endpoints, yet the combination also showed a potential survival benefit.<br />
At...]]></description><link>https://www.newslocker.com/en-us/news/medical/provocative-survival-result-in-myelofibrosis-trial/</link><pubDate>Wed, 03 Jun 2026 17:07:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/news/medical/provocative-survival-result-in-myelofibrosis-trial/</guid></item><item><title><![CDATA[The Missing Congressman; Suspected Ebola Cases Drop; Peabo Bryson Dies]]></title><description><![CDATA[(MedPage Today) -- Note that some links may require registration or subscription.<br />
Rep. Thomas Kean Jr. (R-N.J.) has been absent from Congress for several months due to what he says is a "personal medical issue," and New York Times reporters have...]]></description><link>https://www.newslocker.com/en-us/news/medical/the-missing-congressman-suspected-ebola-cases-drop-peabo-bryson-dies/</link><pubDate>Wed, 03 Jun 2026 15:40:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/news/medical/the-missing-congressman-suspected-ebola-cases-drop-peabo-bryson-dies/</guid></item><item><title><![CDATA[Novel Biologic Performs Well in IgG4-Related Disease]]></title><description><![CDATA[(MedPage Today) -- LONDON--An investigational monoclonal antibody drug for immunoglobulin (Ig)G4-related disease called obexelimab substantially outperformed placebo in the phase III INDIGO trial, researchers reported, positioning it to take...]]></description><link>https://www.newslocker.com/en-us/news/medical/novel-biologic-performs-well-in-igg4-related-disease/</link><pubDate>Wed, 03 Jun 2026 01:01:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/news/medical/novel-biologic-performs-well-in-igg4-related-disease/</guid></item><item><title><![CDATA[GLP-1 Drugs Cut Need for Knee Replacement]]></title><description><![CDATA[(MedPage Today) -- People with knee osteoarthritis (OA) who used GLP-1 receptor agonists were less likely to undergo knee replacement surgery, an analysis of a large records database indicated.<br />
Compared with otherwise similar OA patients not taking...]]></description><link>https://www.newslocker.com/en-us/news/medical/glp-1-drugs-cut-need-for-knee-replacement/</link><pubDate>Wed, 03 Jun 2026 00:30:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/news/medical/glp-1-drugs-cut-need-for-knee-replacement/</guid></item></channel></rss>